Related references
Note: Only part of the references are listed.Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
MaryBeth B. Culp et al.
EUROPEAN UROLOGY (2020)
Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma
C. Bisegna et al.
ANDROLOGY (2020)
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma
Paola Ostano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines
S. Giannattasio et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
E. David Crawford et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes
Vincenzo Di Nunno et al.
CLINICAL GENITOURINARY CANCER (2019)
Aromatase-induced endogenous estrogen promotes tumour metastasis through estrogen receptor-α/matrix metalloproteinase 12 axis activation in castration-resistant prostate cancer
Zhixian Liang et al.
CANCER LETTERS (2019)
Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems
Jo-Fan Chang et al.
FRONTIERS IN ONCOLOGY (2019)
Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression
Helmut Bonkhoff
PROSTATE (2018)
Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise
Semini Sumanasuriya et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Novel imaging of the prostate reveals spontaneous gland contraction and excretory duct quiescence together with different drug effects
Robert Kuegler et al.
FASEB JOURNAL (2018)
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Ekaterina Nevedomskaya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Basal Cells Show Increased Expression of Aromatase and Estrogen Receptor α in Prostate Epithelial Lesions of Male Aging Rats
Monica Morais-Santos et al.
ENDOCRINOLOGY (2018)
A sex-specific dose-response curve for testosterone: could excessive testosterone limit sexual interaction in women?
Jill M. Krapf et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)
Phosphodiesterase type 5 and cancers: progress and challenges
Ines Barone et al.
ONCOTARGET (2017)
Androgen Signaling in Prostate Cancer
Charles Dai et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation
A. Dicitore et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro characterization
Antonio Aversa et al.
ENDOCRINE (2017)
Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy
Stefania Catalano et al.
CLINICAL CANCER RESEARCH (2016)
Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95
Anindita Das et al.
ONCOTARGET (2016)
Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model
A. Aversa et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Phosphodiesterase 5/protein kinase G signal governs sternness of prostate cancer stem cells through Hippo pathway
Naihua Liu et al.
CANCER LETTERS (2016)
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
Kristine M. Wadosky et al.
ONCOTARGET (2016)
Emerging drugs for the treatment of erectile dysfunction
Taylor C. Peak et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate
Wenhao Zhang et al.
SCIENTIFIC REPORTS (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets
F. Ahmad et al.
ORAL DISEASES (2015)
TMPRSS2:ERG Gene Fusion Predicts Subsequent Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia
Kyung Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Advances in targeting cyclic nucleotide phosphodiesterases
Donald H. Maurice et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Incidence rate of prostate cancer in men treated for erectile dysfunction with phosphodiesterase type 5 inhibitors: retrospective analysis
Anthony H. Chavez et al.
ASIAN JOURNAL OF ANDROLOGY (2013)
A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In Vivo
Hidetoshi Kuruma et al.
MOLECULAR CANCER THERAPEUTICS (2013)
For whom the bell (curve) tolls: Cortisol rapidly affects memory retrieval by an inverted U-shaped dose-response relationship
Thomas M. Schilling et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
Tiancheng Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Opposing roles of ERα and ERβ in the genesis and progression of adenocarcinoma in the rat ventral prostate
D. M. A. Attia et al.
PROSTATE (2012)
Tissue physiology and pathology of aromatase
Carlos Stocco
STEROIDS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
Changmeng Cai et al.
CANCER CELL (2011)
Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment
Isaac Levy et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro
Antonio Aversa et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Attenuated Proliferation and Trans-Differentiation of Prostatic Stromal Cells Indicate Suitability of Phosphodiesterase Type 5 Inhibitors for Prevention and Treatment of Benign Prostatic Hyperplasia
Christoph Zenzmaier et al.
ENDOCRINOLOGY (2010)
Targeting cancer with phosphodiesterase inhibitors
Rajkumar Savai et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract
Benedetta Fibbi et al.
JOURNAL OF SEXUAL MEDICINE (2010)
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Sharron H. Francis et al.
PHARMACOLOGICAL REVIEWS (2010)
Long-distance inflammatory and genotoxic impact of cancer in vivo
Jiri Bartek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Evolving Role of Oestrogens and Their Receptors in the Development and Progression of Prostate Cancer
Helmut Bonkhoff et al.
EUROPEAN UROLOGY (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Androgen deprivation therapy for prostate cancer
N Sharifi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer
L Pusztai et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Selective aromatase inhibition for patients with androgen-independent prostate carcinoma
MR Smith et al.
CANCER (2002)
Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor
D Masiello et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function
MF Fu et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate
S Ückert et al.
JOURNAL OF UROLOGY (2001)
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer
MJ Zelefsky et al.
JOURNAL OF UROLOGY (2001)
Molecular biology of the androgen receptor: From molecular understanding to the clinic
IE Eder et al.
EUROPEAN UROLOGY (2001)
p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation
MF Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood
S Migliaccio et al.
BONE (2000)
Share Paper
